Preserving Native Cellulose-Xylan Structure Enables High-Performance Sustainable Nanofibrils
Researchers developed an optimized method to isolate holocellulose nanofibrils (hCNFs) that preserves the native architecture of cellulose and xylan, mimicking the structural design of plant cell walls. The study used multiple plant systems including Arabidopsis mutants and Brassica napus straw to systematically determine how xylan composition and structure affect nanofibril properties. The findings demonstrate that maintaining native cellulose-hemicellulose interactions produces high-performance materials without harsh chemical treatments, offering a sustainable alternative to conventional nanocellulose production.
Researchers developed an optimized isolation strategy for holocellulose nanofibrils (hCNFs) that preserves the native cellulose-xylan architecture found in plant cell walls, addressing a key limitation of conventional production methods that rely on harsh chemical treatments. Using wild-type Arabidopsis thaliana, a xylan glucuronidation-deficient mutant, and Brassica napus straw as model systems, the team systematically investigated how xylan content and substitution patterns influence nanofibril isolation and properties. Advanced characterization techniques including 13C magic-angle spinning NMR and cryogenic transmission electron microscopy confirmed retention of native cellulose structures and xylan conformations, with fibril widths of approximately 3 nm consistent with elementary cellulose microfibrils. The study reveals that xylan glucuronidation regulates colloidal stability and interfibrillar cohesion, while xylan content controls nanofibrillation efficiency. Notably, films produced from Brassica napus hCNFs exhibited exceptional strength and extensibility, surpassing many chemically modified CNF systems, demonstrating that preserving native architecture enables high-performance sustainable materials without chemical reconstruction.
What's missing
The study does not discuss scalability or cost-effectiveness of the optimized isolation strategy compared to conventional methods, nor does it address potential commercial applications or timeline for industrial implementation.
What different sources said
- bioRxivCenter
Preserving Native Cellulose-Xylan Architecture Enables Structure-Property Control in Holocellulose Nanofibrils and High-Performance Sustainable Materials
Related
Study Identifies Microglial Signaling Pathway Linking Stress to Brain Changes
Researchers found that stress activates a microglial signaling pathway (CSF1R) that triggers matrix metalloproteinase activity in the nucleus accumbens, a brain region involved in reward and stress responses. The study used rat models and a CSF1R inhibitor to demonstrate that blocking this pathway reduced stress-induced changes in the brain. This discovery provides insight into the cellular mechanisms by which stress alters brain structure and may inform future treatments for stress-related psychiatric disorders.
Knee Flexion Contracture Alters Neural Control of Ankle Muscles Beyond Mechanical Constraints
A study comparing individuals with chronic knee flexion contracture (KFC) from haemophilia to healthy controls found that KFC produces altered neural activation patterns in ankle plantar flexor muscles during walking. The research used electromyography and coherence analysis to measure muscle activation and neural coordination. The findings suggest that neural adaptations—not just mechanical limitations—drive changes in muscle control during gait in chronic KFC.
Researchers Develop Minimally Invasive Endovascular Neural Interface for Brain Stimulation
Scientists have created a fully endovascular neural implant smaller than 1 cubic millimeter that can be delivered through blood vessels like a stent to stimulate neural circuits. The device uses ultrasound for wireless power and data transmission, and was successfully tested in rabbits to modulate blood pressure through autonomic nervous system stimulation. This technology could enable less invasive alternatives to conventional brain implants for treating neurological and immune disorders.